AdaptHealth Reports Q3 Revenue Growth and $154 Million Attributable Net Loss

What happened

AdaptHealth reported third-quarter 2026 revenue of $745.6 million, up 10.9% from a year earlier, and an attributable net loss of $154.0 million. The loss included a $184.8 million goodwill impairment charge, which means a write-down of acquired business value.

Confirmed

Global impact / market context

The large write-down pushed the company to a net loss even as revenue grew and cash from operations reached $395.6 million over nine months. That gap matters because reported loss can obscure whether the core business still generates cash to fund operations and debt obligations.

Analyst inference

Adjusted EBITDA, which means earnings before interest, taxes, depreciation and amortization with adjustments, fell to $141.9 million from $146.1 million. This signals slightly weaker underlying profitability despite higher sales, so investors may weigh revenue growth against cost pressure and the impairment's one-time nature.

Analyst inference

What to watch

1. Free cash flow was just $2.6 million for the first nine months of 2026, far below the $395.6 million in operating cash flow, so watch what absorbed that cash. Confirmed
2. Management could face questions on whether the $184.8 million goodwill impairment reflects weaker long-term expectations for the businesses tied to that carrying value. Proposed
3. Watch whether the capitated contract, which means fixed payment per patient, keeps improving profitability as lower utilization and reduced labor costs lift results sequentially. Analyst inference

Evidence

• Original source link unavailable